BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1044 related articles for article (PubMed ID: 19565414)

  • 21. A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion.
    Creinin MD; Fox MC; Teal S; Chen A; Schaff EA; Meyn LA;
    Obstet Gynecol; 2004 May; 103(5 Pt 1):851-9. PubMed ID: 15121556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial.
    Creinin MD; Schreiber CA; Bednarek P; Lintu H; Wagner MS; Meyn LA;
    Obstet Gynecol; 2007 Apr; 109(4):885-94. PubMed ID: 17400850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial.
    Diop A; Raghavan S; Rakotovao JP; Comendant R; Blumenthal PD; Winikoff B
    Contraception; 2009 Jun; 79(6):456-62. PubMed ID: 19442782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous administration of mifepristone and misoprostol for early termination of pregnancy: a randomized controlled trial.
    Goel A; Mittal S; Taneja BK; Singal N; Attri S
    Arch Gynecol Obstet; 2011 Jun; 283(6):1409-13. PubMed ID: 21431329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation.
    Tang OS; Chan CC; Kan AS; Ho PC
    Hum Reprod; 2005 Nov; 20(11):3062-6. PubMed ID: 16037110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First trimester abortion with mifepristone and three doses of sublingual misoprostol: a pilot study.
    Singh KC; Ummat S; Rajaram S; Goel N
    Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):495-8. PubMed ID: 16401215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.
    von Hertzen H; Huong NT; Piaggio G; Bayalag M; Cabezas E; Fang AH; Gemzell-Danielsson K; Hinh ND; Mittal S; Ng EH; Chaturachinda K; Pinter B; Puscasiu L; Savardekar L; Shenoy S; Khomassuridge A; Tuyet HT; Velasco A; Peregoudov A;
    BJOG; 2010 Sep; 117(10):1186-96. PubMed ID: 20560941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early pregnancy termination with mifepristone and misoprostol in Norway.
    Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
    Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison or oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion.
    Mittal S; Agarwal S; Kumar S; Batra A
    Indian J Med Res; 2005 Aug; 122(2):132-6. PubMed ID: 16177470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study supports the introduction of early medical abortion in Turkey.
    Akin A; Kocoglu GO; Akin L
    Reprod Health Matters; 2005 Nov; 13(26):101-9. PubMed ID: 16291491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An outpatient regimen of combined oral mifepristone 400 mg and misoprostol 400 microg for first-trimester legal medical abortion.
    Ravn P; Rasmussen A; Knudsen UB; Kristiansen FV
    Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1098-102. PubMed ID: 16232179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation.
    Tang OS; Xu J; Cheng L; Lee SW; Ho PC
    Hum Reprod; 2002 Jul; 17(7):1738-40. PubMed ID: 12093832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study.
    Lohr PA; Reeves MF; Hayes JL; Harwood B; Creinin MD
    Contraception; 2007 Sep; 76(3):215-20. PubMed ID: 17707719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-emptive effect of ibuprofen versus placebo on pain relief and success rates of medical abortion: a double-blind, randomized, controlled study.
    Avraham S; Gat I; Duvdevani NR; Haas J; Frenkel Y; Seidman DS
    Fertil Steril; 2012 Mar; 97(3):612-5. PubMed ID: 22265034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
    Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
    Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medical abortion--the first Norwegian experiences].
    Iversen OE; Midbøe G; Johnsen SL; Augestad G; Økland I; Helland H; Strray-Pedersen S; Bjørge L
    Tidsskr Nor Laegeforen; 2003 Sep; 123(17):2422-4. PubMed ID: 14594047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion.
    Schaff EA; Stadalius LS; Eisinger SH; Franks P
    J Fam Pract; 1997 Apr; 44(4):353-60. PubMed ID: 9108832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam.
    Ngoc NT; Nhan VQ; Blum J; Mai TT; Durocher JM; Winikoff B
    BJOG; 2004 Aug; 111(8):814-9. PubMed ID: 15270929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.